Search Results - "Sevilimedu, Varadan"

Refine Results
  1. 1

    A Review of the Estimation of Sensitivity and Specificity in the Context of Time‐Dependent Outcomes by Sevilimedu, Varadan, Pangan, Giuseppe, Pinker, Katja

    Published in Journal of magnetic resonance imaging (01-08-2024)
    “…Time is an essential element in the field of survival analysis. Time to an event is essential in adjudicating diagnostic utility and determining the…”
    Get full text
    Journal Article
  2. 2

    Simulation extrapolation method for measurement error: A review by Sevilimedu, Varadan, Yu, Lili

    Published in Statistical methods in medical research (01-08-2022)
    “…Measurement error is pervasive in statistics due to the non-availability of authentic data. The reasons for measurement error mainly relate to cost,…”
    Get full text
    Book Review Journal Article
  3. 3

    Palpable Adenopathy Does Not Indicate High-Volume Axillary Nodal Disease in Hormone Receptor-Positive Breast Cancer by Crown, Angelena, Sevilimedu, Varadan, Morrow, Monica

    Published in Annals of surgical oncology (01-10-2021)
    “…Background Axillary metastases in the form of palpable adenopathy indicate the need for neoadjuvant chemotherapy or axillary lymph node dissection (ALND)…”
    Get full text
    Journal Article
  4. 4

    Local Recurrence is Frequent After Heroic Mastectomy for Classically Inoperable Breast Cancers by Mamtani, Anita, Sevilimedu, Varadan, Vincent, Alain, Morrow, Monica

    Published in Annals of surgical oncology (01-02-2022)
    “…Background Despite advances in neoadjuvant systemic therapy (NST), some patients with aggressive T4 breast cancers do not respond. The efficacy of ‘heroic’…”
    Get full text
    Journal Article
  5. 5
  6. 6

    How Often Does Modern Neoadjuvant Chemotherapy Downstage Patients to Breast-Conserving Surgery? by Petruolo, Oriana, Sevilimedu, Varadan, Montagna, Giacomo, Le, Tiana, Morrow, Monica, Barrio, Andrea V.

    Published in Annals of surgical oncology (01-01-2021)
    “…Background Neoadjuvant chemotherapy (NAC) has been proven to increase breast-conserving surgery (BCS) rates, but data are limited on conversion rates from…”
    Get full text
    Journal Article
  7. 7

    Misclassification simulation extrapolation method for a Weibull accelerated failure time model by Sevilimedu, Varadan, Yu, Lili, Samawi, Hani

    Published in Statistical methods in medical research (01-08-2023)
    “…The problem of misclassification in covariates is ubiquitous in survival data and often leads to biased estimates. The misclassification simulation…”
    Get full text
    Journal Article
  8. 8

    Comparison of Outcomes for Classic-Type Lobular Carcinoma In Situ Managed with Surgical Excision After Core Biopsy Versus Observation by Matar, Regina, Sevilimedu, Varadan, Park, Anna, King, Tari A., Pilewskie, Melissa

    Published in Annals of surgical oncology (01-03-2022)
    “…Background Studies report low upgrade rates following excision for classic-type lobular carcinoma in situ (LCIS) with radiologic-pathologic concordance. Thus,…”
    Get full text
    Journal Article
  9. 9

    Margin Width and Local Recurrence in Patients Undergoing Breast Conservation After Neoadjuvant Chemotherapy by Mrdutt, Mary, Heerdt, Alexandra, Sevilimedu, Varadan, Mamtani, Anita, Barrio, Andrea, Morrow, Monica

    Published in Annals of surgical oncology (01-01-2022)
    “…Background A margin of “no ink on tumor” has been established for primary breast conservation therapy (BCT), but the appropriate margin following neoadjuvant…”
    Get full text
    Journal Article
  10. 10

    Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype by Tadros, Audree B., Sevilimedu, Varadan, Giri, Dilip D., Zabor, Emily C., Morrow, Monica, Plitas, George

    Published in Annals of surgical oncology (01-08-2021)
    “…Background Metaplastic breast carcinoma (MBC) is a rare, aggressive subtype of breast cancer associated with poorer overall survival than other triple-negative…”
    Get full text
    Journal Article
  11. 11

    Is local recurrence higher among patients who downstage to breast conservation after neoadjuvant chemotherapy? by Mamtani, Anita, Sevilimedu, Varadan, Le, Tiana, Morrow, Monica, Barrio, Andrea V.

    Published in Cancer (01-02-2022)
    “…Background In early studies, local recurrence (LR) rates were higher after neoadjuvant chemotherapy (NAC) in comparison with upfront surgery. Modern outcomes…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16

    Can We Successfully De-Escalate Axillary Surgery in Women Aged ≥ 70 Years with Ductal Carcinoma in Situ or Early-Stage Breast Cancer Undergoing Mastectomy? by Matar, Regina, Barrio, Andrea V., Sevilimedu, Varadan, Le, Tiana, Heerdt, Alexandra, Morrow, Monica, Tadros, Audree

    Published in Annals of surgical oncology (01-04-2022)
    “…Background Omission of sentinel lymph node biopsy (SLNB) in older women with clinically node-negative, hormone receptor-positive (HR+) early-stage breast…”
    Get full text
    Journal Article
  17. 17

    Timing of Presentation and Outcomes of Women with Stage IV Pregnancy-Associated Breast Cancer (PABC) by Matar, Regina, Crown, Angelena, Sevilimedu, Varadan, Goldfarb, Shari B., Gemignani, Mary L.

    Published in Annals of surgical oncology (01-03-2022)
    “…Background Pregnancy-associated breast cancer (PABC) and concurrent, or early development of, stage IV disease is uncommon. Given this rarity, and complexities…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20